906.1500 1.85 (0.20%)
NSE Oct 03, 2025 14:16 PM
Volume: 32,902
 

906.15
0.20%
ICICI Securities Limited
On the business front, despite the nationwide lockdown, domestic growth is expected to remain more or less stable. Exports growth, barring for one or two months due to congestion in all major ports globally, is also expected to remain strong due to 1) currency benefit, 2) slowdown in competition due to delay in new approvals that will be beneficial for existing players and 3) expected demand continuum across the world despite Covid-19. Some windfall is also expected in some critical productsa case in point is Hydroxychloroquine, a malaria drug that is likely to be repurposed as a prophylaxis for Covid-19 treatment in some cases....
Number of FII/FPI investors decreased from 198 to 192 in Jun 2025 qtr
More from Alembic Pharmaceuticals Ltd.
Recommended